Can a 30-minute bike ride help fight liver cancer? scientists investigate.
NCT ID NCT07189624
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will look at how a single 30-minute bike ride changes levels of certain liver proteins (FGF21 and follistatin) in 12 people with liver cancer. Researchers want to understand how exercise affects the body in these patients, which could lead to better exercise recommendations. The study does not test any drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors design safe and effective exercise programs for people with liver cancer.
- What could go wrong
- This is a very small, early study (12 people) that only looks at short-term changes after one exercise session. It won't test whether exercise improves health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS WITH HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, France
-
Chu Estaing Medecine Digestive Et Hepatobiliaire
Clermont-Ferrand, 63003, France